Strengthening preparedness and response capabilities for emerging infectious diseases

• Infectious diseases spread through bioterrorism or infectious diseases with a high mortality rate or a high risk of mass outbreak, requiring immediate reporting on the outbreak or epidemic thereof as well as high-level isolation, such as negative pressure isolation

• Ebola virus disease, Marburg hemorrhagic fever, Lassa fever, Crimean-Congo hemorrhagic fever, South American hemorrhagic fever
• Smallpox, Pest, Anthrax, Botulism, Tularaemia
• Emerging infectious disease syndrome.
• Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS)
• Human Infection with Avian Influenza
• Novel influenza
• Diphtheria (under the jurisdiction of the Infectious Disease Control Division)

• Class 1 Infectious Disease Viral Hemorrhagic Fever Response Guidelines
• Class 1 Infectious Disease Response Guidelines for Smallpox, Pest, Anthrax, Botulism, and Tularemia
• Class 1 Infectious Disease Response Guidelines for Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS)
• Class 1 Infectious Disease Response Guidelines for Human Infection with Avian Influenza

• The person obligated to report must submit the infectious disease occurrence or death (post-mortem examination) report, etc., to the head of the health center that has jurisdiction over the location of the infectious disease patient or the reporter using an information system or by fax.
• In the case of Class 1 infectious diseases, the obligor must inform the head of the relevant health center or the Commissioner of the Korea Disease Control and Prevention Agency verbally or by phone before submitting the report. Korea Disease Control and Prevention Agency Comprehensive Situation Room (043-719-7979) and Regional Disease Response Centers
• When a report is received by the Korea Disease Control and Prevention Agency (Comprehensive Situation Room), the Comprehensive Situation Room will immediately relay the relevant information to the pertinent regional disease response center (hereinafter referred to as the regional center), related departments of the Korea Disease Control and Prevention Agency, and local governments by phone. The provinces will coordinate with the relevant health centers to implement actions according to the response guidelines for each infectious disease.

Applicable only to Middle East Respiratory Syndrome (MERS).

• Among the 722 suspected reports of Class 1 infectious diseases in 2024, a total of 97 cases (72 cases of MERS, 17 cases of AI human infection, 4 cases of tularemia, 2 cases of pest, and 1 case each of Lassa fever and botulism) were classified as suspected cases and underwent testing.
• No confirmed cases have been reported.